OTCM
GRGBF
Market cap8mUSD
, Last price
USD
Name
Greenrise Global Brands Inc
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
35.83%
Rev. gr., 5y
-68.38%
Revenues
0k
Net income
-722k
L+141.57%
CFO
-176k
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Greenrise Global Brands Inc., operating through its various subsidiaries, serves as a pharmaceutical distributor, providing medical cannabis products to pharmacies throughout Germany. The company also offers a broad selection of CBD-infused items, such as tinctures, sprays, oils, and skincare products, which are retailed in drugstores. Additionally, it is involved in the importation and sale of medical and cosmetic cannabis goods that meet stringent EU-GMP quality standards. The firm was formerly recognized as AMP Alternative Medical Products Inc. before officially changing its name to Greenrise Global Brands Inc. in November 2021. Its main corporate offices are located in Vancouver, Canada.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||